188 related articles for article (PubMed ID: 21864353)
1. Group medical visits in the follow-up of women with a BRCA mutation: design of a randomized controlled trial.
Visser A; Prins JB; Hoogerbrugge N; van Laarhoven HW
BMC Womens Health; 2011 Aug; 11():39. PubMed ID: 21864353
[TBL] [Abstract][Full Text] [Related]
2. Peer support and additional information in group medical consultations (GMCs) for BRCA1/2 mutation carriers: A randomized controlled trial.
Visser A; van Laarhoven HW; Woldringh GH; Hoogerbrugge N; Prins JB
Acta Oncol; 2016; 55(2):178-87. PubMed ID: 26114234
[TBL] [Abstract][Full Text] [Related]
3. Bilateral prophylactic mastectomy in BRCA mutation carriers: what surgeons need to know.
Franceschini G; Di Leone A; Terribile D; Sanchez MA; Masetti R
Ann Ital Chir; 2019; 90():1-2. PubMed ID: 30872561
[TBL] [Abstract][Full Text] [Related]
4. Group medical consultations (GMCs) and tablet-based online support group sessions in the follow-up of breast cancer: A multicenter randomized controlled trial.
Visser A; Prins JB; Jansen L; Radema SA; Schlooz MS; van Dalen T; van Laarhoven HWM
Breast; 2018 Aug; 40():181-188. PubMed ID: 29906741
[TBL] [Abstract][Full Text] [Related]
5. Effect of Inquiry-Based Stress Reduction on Well-being and Views on Risk-Reducing Surgery Among Women With BRCA Variants in Israel: A Randomized Clinical Trial.
Landau C; Novak AM; Ganz AB; Rolnik B; Friedman E; Lev-Ari S
JAMA Netw Open; 2021 Dec; 4(12):e2139670. PubMed ID: 34962562
[TBL] [Abstract][Full Text] [Related]
6. Group medical consultations in the follow-up of breast cancer: a randomized feasibility study.
Visser A; van Laarhoven HW; Govaert PH; Schlooz MS; Jansen L; van Dalen T; Prins JB
J Cancer Surviv; 2015 Sep; 9(3):450-61. PubMed ID: 25579623
[TBL] [Abstract][Full Text] [Related]
7. Breast self-examination education for BRCA mutation carriers by clinical nurse specialists.
Visser A; Bos WC; Prins JB; Hoogerbrugge N; van Laarhoven HW
Clin Nurse Spec; 2015; 29(3):E1-7. PubMed ID: 25856039
[TBL] [Abstract][Full Text] [Related]
8. Behavioral and psychosocial effects of rapid genetic counseling and testing in newly diagnosed breast cancer patients: design of a multicenter randomized clinical trial.
Wevers MR; Ausems MG; Verhoef S; Bleiker EM; Hahn DE; Hogervorst FB; van der Luijt RB; Valdimarsdottir HB; van Hillegersberg R; Rutgers EJ; Aaronson NK
BMC Cancer; 2011 Jan; 11():6. PubMed ID: 21219598
[TBL] [Abstract][Full Text] [Related]
9. Effects of lifestyle intervention in BRCA1/2 mutation carriers on nutrition, BMI, and physical fitness (LIBRE study): study protocol for a randomized controlled trial.
Kiechle M; Engel C; Berling A; Hebestreit K; Bischoff SC; Dukatz R; Siniatchkin M; Pfeifer K; Grill S; Yahiaoui-Doktor M; Kirsch E; Niederberger U; Enders U; Löffler M; Meindl A; Rhiem K; Schmutzler R; Erickson N; Halle M
Trials; 2016 Jul; 17():368. PubMed ID: 27473440
[TBL] [Abstract][Full Text] [Related]
10. One year follow-up of women opting for presymptomatic testing for BRCA1 and BRCA2: emotional impact of the test outcome and decisions on risk management (surveillance or prophylactic surgery).
Lodder LN; Frets PG; Trijsburg RW; Meijers-Heijboer EJ; Klijn JG; Seynaeve C; van Geel AN; Tilanus MM; Bartels CC; Verhoog LC; Brekelmans CT; Burger CW; Niermeijer MF
Breast Cancer Res Treat; 2002 May; 73(2):97-112. PubMed ID: 12088120
[TBL] [Abstract][Full Text] [Related]
11. Implementation and evaluation of a nurse-led decision-coaching program for healthy breast cancer susceptibility gene (BRCA1/2) mutation carriers: a study protocol for the randomized controlled EDCP-BRCA study.
Isselhard A; Töpper M; Berger-Höger B; Steckelberg A; Fischer H; Vitinius F; Beifus K; Köberlein-Neu J; Wiedemann R; Rhiem K; Schmutzler R; Stock S
Trials; 2020 Jun; 21(1):501. PubMed ID: 32513307
[TBL] [Abstract][Full Text] [Related]
12. How should we discuss genetic testing with women newly diagnosed with breast cancer? Design and implementation of a randomized controlled trial of two models of delivering education about treatment-focused genetic testing to younger women newly diagnosed with breast cancer.
Watts KJ; Meiser B; Mitchell G; Kirk J; Saunders C; Peate M; Duffy J; Kelly PJ; Gleeson M; Barlow-Stewart K; Rahman B; Friedlander M; Tucker K;
BMC Cancer; 2012 Jul; 12():320. PubMed ID: 22838957
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of preventive strategies for women with a BRCA1 or a BRCA2 mutation.
Anderson K; Jacobson JS; Heitjan DF; Zivin JG; Hershman D; Neugut AI; Grann VR
Ann Intern Med; 2006 Mar; 144(6):397-406. PubMed ID: 16549852
[TBL] [Abstract][Full Text] [Related]
14. Randomized trial of a decision aid for BRCA1/BRCA2 mutation carriers: impact on measures of decision making and satisfaction.
Schwartz MD; Valdimarsdottir HB; DeMarco TA; Peshkin BN; Lawrence W; Rispoli J; Brown K; Isaacs C; O'Neill S; Shelby R; Grumet SC; McGovern MM; Garnett S; Bremer H; Leaman S; O'Mara K; Kelleher S; Komaridis K
Health Psychol; 2009 Jan; 28(1):11-19. PubMed ID: 19210013
[TBL] [Abstract][Full Text] [Related]
15. Randomized trial of a shared decision-making intervention consisting of trade-offs and individualized treatment information for BRCA1/2 mutation carriers.
van Roosmalen MS; Stalmeier PF; Verhoef LC; Hoekstra-Weebers JE; Oosterwijk JC; Hoogerbrugge N; Moog U; van Daal WA
J Clin Oncol; 2004 Aug; 22(16):3293-301. PubMed ID: 15310772
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal changes in patient distress following interactive decision aid use among BRCA1/2 carriers: a randomized trial.
Hooker GW; Leventhal KG; DeMarco T; Peshkin BN; Finch C; Wahl E; Joines JR; Brown K; Valdimarsdottir H; Schwartz MD
Med Decis Making; 2011; 31(3):412-21. PubMed ID: 20876346
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer treatment in mutation carriers: surgical treatment.
Biglia N; D'Alonzo M; Sgro LG; Tomasi Cont N; Bounous V; Robba E
Minerva Ginecol; 2016 Oct; 68(5):548-56. PubMed ID: 26822896
[TBL] [Abstract][Full Text] [Related]
18. Nipple-sparing bilateral prophylactic mastectomy and immediate reconstruction with TiLoop
Casella D; Di Taranto G; Marcasciano M; Sordi S; Kothari A; Kovacs T; Lo Torto F; Cigna E; Ribuffo D; Calabrese C
Breast; 2018 Jun; 39():8-13. PubMed ID: 29455110
[TBL] [Abstract][Full Text] [Related]
19. Female BRCA mutation carriers with a preference for prophylactic mastectomy are more likely to participate an educational-support group and to proceed with the preferred intervention within 2 years.
Landsbergen KM; Prins JB; Kamm YJ; Brunner HG; Hoogerbrugge N
Fam Cancer; 2010 Jun; 9(2):213-20. PubMed ID: 19967456
[TBL] [Abstract][Full Text] [Related]
20. DNA-testing for BRCA1/2 prior to genetic counselling in patients with breast cancer: design of an intervention study, DNA-direct.
Sie AS; Spruijt L; van Zelst-Stams WA; Mensenkamp AR; Ligtenberg MJ; Brunner HG; Prins JB; Hoogerbrugge N
BMC Womens Health; 2012 May; 12():12. PubMed ID: 22569005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
